Sort
64,565 grants matching “drug discovery”
Basic and Translational Studies of Inborn Errors of Metabolism
$2,273,609Forbes Porter · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2024 · HD
Cancer Center Support Grant
$2,273,410Roy A. Jensen · University Of Kansas Medical Center · P30 · FY2019 · CA
Cancer Center Support Grant
$2,272,619Roy A. Jensen · University Of Kansas Medical Center · P30 · FY2020 · CA
Chemical Biology of Infectious Disease
$2,272,500Phillip Scott Hefty · University Of Kansas Lawrence · P20 · FY2019 · GM
Chemical Biology of Infectious Disease
$2,272,500Phillip Scott Hefty · University Of Kansas Lawrence · P20 · FY2025 · GM
Chemical Biology of Infectious Disease
$2,272,500Phillip Scott Hefty · University Of Kansas Lawrence · P20 · FY2020 · GM
Chemical Biology of Infectious Disease
$2,272,500Phillip Scott Hefty · University Of Kansas Lawrence · P20 · FY2024 · GM
Mayo Clinic Breast Cancer SPORE
$2,272,470Matthew Philip Goetz · Mayo Clinic Rochester · P50 · FY2019 · CA
Preclinical drug development in pancreatic cancer
$2,272,436Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Mitochondrial Complex I as a Target for Neuroprotection in AD
$2,271,860Eugenia Trushina · Mayo Clinic Rochester · RF1 · FY2022 · AG
Cancer Center Support Grant
$2,271,814Roy A. Jensen · University Of Kansas Medical Center · P30 · FY2021 · CA
Harvard-wide Program on Antibiotic Resistance
$2,271,745Michael S. Gilmore · Massachusetts Eye And Ear Infirmary · P01 · FY2024 · AI
Development of inhibitors of AMP Deaminase Isoform 2 as a Mechanism for Treating
$2,271,441Richard Joseph Johnson · University Of Colorado Denver · RC4 · FY2010 · DK
Chemical Approaches to Modulate PAX3-FOXO1 in Fusion-Positive Alveolar Rhabdomyosarcoma
$2,271,313Angela Nicole Koehler · Massachusetts Institute Of Technology · UM1 · FY2025 · CA
Integrating preclinical models to develop converging mechanistic data in co-occurring HIV and substance use
$2,270,625Jacqueline M Barker · Drexel University · DP2 · FY2020 · DA
3D Bioprinted skin models for drug screening
$2,269,070Marc Ferrer · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR
3D Bioprinted lung cancer models for drug screening
$2,269,070Marc Ferrer · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR
CCR Office of Training and Education
$2,268,673Jonathan Scott Wiest · Division Of Basic Sciences - Nci · ZIJ · FY2009 · CA
NATIONAL BIOMEDICAL COMPUTATION RESOURCE
$2,268,147Peter William Arzberger · University Of California, San Diego · P41 · FY2010 · RR
Chemical Biology of Infectious Disease
$2,267,942Phillip Scott Hefty · University Of Kansas Lawrence · P20 · FY2022 · GM
Chemical Biology of Infectious Disease
$2,267,942Phillip Scott Hefty · University Of Kansas Lawrence · P20 · FY2023 · GM
Chemical Biology of Infectious Disease
$2,267,942Phillip Scott Hefty · University Of Kansas Lawrence · P20 · FY2021 · GM
A New Paradigm in Nanomedicine: can structural interiors of nanoparticles regulate cellular delivery?
$2,267,514Cecilia Maria Leal · University Of Illinois At Urbana-Champaign · DP2 · FY2016 · EB
Chemical Biology of Infectious Disease
$2,265,277Thomas Edward Prisinzano · University Of Kansas Lawrence · P20 · FY2017 · GM
Novel commensal polysaccharide treats multiple sclerosis through Treg modulation
$2,264,726Lloyd H Kasper · Symbiotix Biotherapies, Inc. · R42 · FY2015 · AI